Rasagin 0.5mg Tablet
By Rasagin
Rx
30 Tablet in a Strip

Composition
Rasagiline(0.5mg)

Manufacturer - Natco Pharma Ltd
Natco House, Road No.2, Banjara Hills, Hyderabad-500 034, India

Expires on or after
July, 2026
About Rasagin 0.5mg Tablet
Rasagin 0.5mg Tablet is a medication primarily used in the treatment of Parkinson's disease. Its main function is to enhance the control of body movements and reduce the occurrence of excessive shaking and stiffness commonly associated with the condition. This medication can be administered either on its own or alongside other prescribed medications. Patients have the flexibility to take Rasagin 0.5mg Tablet with or without food, although it is recommended to adopt a consistent daily dosing schedule to ensure a steady level of the medicine in the body. It is crucial to adhere to the dosage and duration instructions provided by your healthcare provider. In case a dose is missed, it is advisable to take it promptly upon recollection to maintain the treatment regimen's effectiveness.
It is important not to skip any doses and complete the entire course of treatment, even if symptoms improve. Abruptly discontinuing the medication without consulting a healthcare professional can lead to adverse effects such as confusion, muscle stiffness, and high fever. Patients should be aware of potential side effects associated with Rasagin 0.5mg Tablet, including joint pain, insomnia, indigestion, cold-like symptoms, depression, cough, and peripheral edema. Furthermore, this medication can induce dizziness and drowsiness, prompting individuals to avoid activities that require mental alertness until the impact of the medicine is understood.
Regular monitoring is recommended while taking Rasagin 0.5mg Tablet, specifically to detect any signs of skin cancer, as there is an elevated risk of developing cancer with its use. Any unusual changes in mood, hallucinations, increased sex drive, gambling urges, or uncontrolled spending should be promptly reported to a healthcare provider as these symptoms could pose significant risks. It is essential for patients to maintain open communication with their doctor throughout the treatment process to address any concerns or potential complications effectively.
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹135
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024
